长春西汀治疗慢性脑供血不足的临床效果

Clinical effect of Vinpocetine in the treatment of chronic cerebral insufficiency

目的探讨长春西汀对慢性脑供血不足患者的临床效果。方法选取我院2016年5月~2019年5月收治的42例慢性脑供血不足患者作为研究对象,用抽签法随机分为对照组和观察组,各21例,在常规治疗基础上,对照组给予银杏达莫注射液治疗,观察组给予长春西汀治疗,比较两组患者的临床有效率、治疗前后的血流速度及不良反应发生情况。结果观察组患者的临床总有效率高于对照组,差异有统计学意义(P<0.05);治疗前两组患者的血流速度比较,差异无统计学意义(P>0.05);治疗后观察组的血流速度快于对照组,差异有统计学意义(P<0.05);观察组的不良反应总发生率低于对照组,差异有统计学意义(P<0.05)。结论长春西汀可提高慢性脑供血不足患者的临床有效率,药物不良反应小,值得推广。

Objective To investigate the clinical effect of Vinpocetine on patients with chronic cerebral insufficiency.Methods Forty-two patients with chronic cerebral insufficiency who were treated in our hospital from May 2016 to May 2019 were randomly divided into the control group and the observation group by lottery,each group had 21 patients,on the bases of conventional treatment,the control group accepted Ginkgo Damamo Injection,and the observation group accepted Vnpocetine,and the clinical effectiveness,blood flow rate and adverse reactions before and after treatment were compared between the two groups.Results The total clinical effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).There was no significant difference in blood flow velocity of patients between the two groups before treatment,the difference was not statistically significant(P>0.05).The blood flow velocity after treatment was faster than that of the control group,the difference was statistically significant(P<0.05).The total incidence of adverse reactions was lower than that of the control group,the difference was statistically significant(P<0.05).Conclusion Vinpocetine can improve the clinical efficiency of patients with chronic cerebral insufficiency,and the adverse drug reactions are small,which is worth promoting.